Healthcare provider profile · identity verified

Stanley Ofori, MD

Internal Medicine · TUCSON, AZ · NPI 1093793648

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1116	380
Amlodipine Besylate	Amlodipine Besylate	746	252
Levothyroxine Sodium	Levothyroxine Sodium	653	186
Metformin Hcl	Metformin Hcl	594	203
Lisinopril	Lisinopril	558	169
Fluticasone Propionate	Fluticasone Propionate	438	253
Losartan Potassium	Losartan Potassium	398	142
Pantoprazole Sodium	Pantoprazole Sodium	377	159
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	353	110
Rosuvastatin Calcium	Rosuvastatin Calcium	352	113
Gabapentin	Gabapentin	318	141
Tamsulosin Hcl	Tamsulosin Hcl	299	106
Citalopram Hbr	Citalopram Hydrobromide	261	90
Glipizide	Glipizide	249	86
Simvastatin	Simvastatin	235	74
Metoprolol Succinate	Metoprolol Succinate	226	75
Hydrochlorothiazide	Hydrochlorothiazide	214	82
Prednisone	Prednisone	206	158
Omeprazole	Omeprazole	203	71
Famotidine	Famotidine	195	92
Metoprolol Tartrate	Metoprolol Tartrate	194	64
Sertraline Hcl	Sertraline Hcl	177	56
Montelukast Sodium	Montelukast Sodium	172	58
Albuterol Sulfate Hfa	Albuterol Sulfate	161	62
Alendronate Sodium	Alendronate Sodium	153	59
Eliquis	Apixaban	152	47
Finasteride	Finasteride	152	48
Nifedipine Er	Nifedipine	148	49
Furosemide	Furosemide	147	57
Mirtazapine	Mirtazapine	145	56
Atenolol	Atenolol	144	44
Duloxetine Hcl	Duloxetine Hcl	144	51
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	141	49
Allopurinol	Allopurinol	127	42
Carvedilol	Carvedilol	127	44
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	123	43
Trazodone Hcl	Trazodone Hcl	114	44
Pioglitazone Hcl	Pioglitazone Hcl	111	41
Potassium Chloride	Potassium Chloride	106	51
Donepezil Hcl	Donepezil Hcl	105	38
Ozempic	Semaglutide	104	27
Folic Acid	Folic Acid	99	43
Buspirone Hcl	Buspirone Hcl	97	32
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	90	65
Felodipine Er	Felodipine	89	25
Januvia	Sitagliptin Phosphate	89	20
Labetalol Hcl	Labetalol Hcl	89	27
Chlorthalidone	Chlorthalidone	88	30
Cephalexin	Cephalexin	87	66
Doxycycline Hyclate	Doxycycline Hyclate	85	68
Pravastatin Sodium	Pravastatin Sodium	83	26
Lovastatin	Lovastatin	82	23
Clopidogrel	Clopidogrel Bisulfate	81	24
Hydralazine Hcl	Hydralazine Hcl	78	29
Azelastine Hcl	Azelastine Hcl	76	41
Metformin Hcl Er	Metformin Hcl	76	28
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	76	25
Diclofenac Sodium	Diclofenac Sodium	74	54
Dicyclomine Hcl	Dicyclomine Hcl	72	29
Celecoxib	Celecoxib	71	41
Ezetimibe	Ezetimibe	69	28
Doxazosin Mesylate	Doxazosin Mesylate	64	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	63	21
Aripiprazole	Aripiprazole	62	24
Meclizine Hcl	Meclizine Hcl	59	33
Oxybutynin Chloride Er	Oxybutynin Chloride	58	22
Spironolactone	Spironolactone	58	24
Mounjaro	Tirzepatide	57	suppressed
Sucralfate	Sucralfate	54	28
Fenofibrate	Fenofibrate Nanocrystallized	53	26
Propranolol Hcl	Propranolol Hcl	53	19
Zolpidem Tartrate	Zolpidem Tartrate	52	suppressed
Azithromycin	Azithromycin	47	44
Glimepiride	Glimepiride	47	14
Trulicity	Dulaglutide	44	14
Meloxicam	Meloxicam	43	17
Xarelto	Rivaroxaban	43	14
Bisoprolol Fumarate	Bisoprolol Fumarate	42	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	39
Baclofen	Baclofen	41	24
Paroxetine Hcl	Paroxetine Hcl	39	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	14
Escitalopram Oxalate	Escitalopram Oxalate	38	12
Esomeprazole Magnesium	Esomeprazole Magnesium	38	11
Naproxen	Naproxen	35	29
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	14
Vitamin D2	Ergocalciferol (Vitamin D2)	35	27
Acetaminophen-Codeine	Acetaminophen With Codeine	34	suppressed
Farxiga	Dapagliflozin Propanediol	34	11
Metoclopramide Hcl	Metoclopramide Hcl	33	23
Synthroid	Levothyroxine Sodium	33	13
Triamcinolone Acetonide	Triamcinolone Acetonide	33	25
Tolterodine Tartrate Er	Tolterodine Tartrate	32	14
Clobetasol Propionate	Clobetasol Propionate	30	18
Levetiracetam	Levetiracetam	30	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	14
Quetiapine Fumarate	Quetiapine Fumarate	30	12
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	12
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Bupropion Hcl Sr	Bupropion Hcl	28	15
Ondansetron Hcl	Ondansetron Hcl	28	18
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Jardiance	Empagliflozin	27	suppressed
Methenamine Hippurate	Methenamine Hippurate	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	16
Clonidine Hcl	Clonidine Hcl	24	11
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	23	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	18
Colchicine	Colchicine	22	suppressed
Ibuprofen	Ibuprofen	22	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	20
Solifenacin Succinate	Solifenacin Succinate	21	12
Lidocaine	Lidocaine	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Primidone	Primidone	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Ondansetron Odt	Ondansetron	18	12
Valsartan	Valsartan	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Estradiol	Estradiol	15	suppressed
Flecainide Acetate	Flecainide Acetate	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	15	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Irbesartan	Irbesartan	13	suppressed
Nystatin	Nystatin	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Ingrezza	Valbenazine Tosylate	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Linzess	Linaclotide	11	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error